Northwest Biotherapeutics (NWBO) Operating Income Growth (3y) (2013 - 2026)
Northwest Biotherapeutics (NWBO) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 55.96% |
| 10 | Northwest Biotherapeutics | 277.35 Mn | 275.56 Mn | - | 5.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.62% |
| Dec 31, 2025 | 9.43% |
| Sep 30, 2025 | 2.85% |
| Jun 30, 2025 | 11.19% |
| Mar 31, 2025 | -12.11% |
| Dec 31, 2024 | -20.11% |
| Sep 30, 2024 | -13.78% |
| Jun 30, 2024 | -12.07% |
| Mar 31, 2024 | 6.99% |
| Dec 31, 2023 | 13.45% |
| Sep 30, 2023 | 33.90% |
| Jun 30, 2023 | -21.68% |
| Mar 31, 2023 | -18.29% |
| Dec 31, 2022 | -39.25% |
| Sep 30, 2022 | -33.36% |
| Jun 30, 2022 | -47.04% |
| Mar 31, 2022 | -16.52% |
| Dec 31, 2021 | -52.81% |
| Sep 30, 2021 | -2.55% |
| Jun 30, 2021 | 15.21% |